Literature DB >> 16380822

Molecular aspects of regulation of collagen gene expression in fibrosis.

Rashpal K Bhogal1, Cristina M Stoica, Tracy L McGaha, Constantin A Bona.   

Abstract

Fibrosis, the hyper-accumulation of scar tissue, is characterized by the overproduction and deposition of type I and III collagen by fibroblasts and is the one of the main pathologic outcomes of the autoimmune disorder scleroderma. While the causes of fibrosis in scleroderma are unknown, cytokines such as TGF-beta, IL-4 and IL-13, play a crucial role in the stimulation of collagen production have been implicated in the disease process. In fibroblasts stimulation of collagen production by these cytokines is dependent on the Smad and STAT6 signaling pathways induced by TGF-beta and IL-4, IL-13 respectively. Furthermore, mounting evidence suggest cytokine crosstalk is relevant in the sclerotic process. Our laboratory demonstrated an increase in TGF-beta1 gene transcription from fibroblasts stimulated with IL-4. In addition, TSK/+ mice lacking the IL-4alpha receptor show impaired transcription of the TGF-beta1 gene and did not display fibrosis. Likewise, it appears that STAT6 plays a role in fibroblast TGF-beta1 transcription after IL-4 or IL-13 stimulation. These findings suggest that an epistatic interaction between IL-4 and TGF-beta may exist which is crucial for pathologic sclerotic activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16380822     DOI: 10.1007/s10875-005-7827-3

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  81 in total

Review 1.  Cutaneous wound healing.

Authors:  A J Singer; R A Clark
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

Review 2.  Scleroderma and Smads: dysfunctional Smad family dynamics culminating in fibrosis.

Authors:  John Varga
Journal:  Arthritis Rheum       Date:  2002-07

Review 3.  Structure and biological activity of the extracellular matrix.

Authors:  M Aumailley; B Gayraud
Journal:  J Mol Med (Berl)       Date:  1998-03       Impact factor: 4.599

Review 4.  Cytokine directed therapy in scleroderma: rationale, current status, and the future.

Authors:  Robert W Simms; Joseph H Korn
Journal:  Curr Opin Rheumatol       Date:  2002-11       Impact factor: 5.006

5.  MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data.

Authors:  K Quandt; K Frech; H Karas; E Wingender; T Werner
Journal:  Nucleic Acids Res       Date:  1995-12-11       Impact factor: 16.971

6.  Hereditary emphysema in the tight-skin mouse. Evaluation of pathogenesis.

Authors:  G A Rossi; G W Hunninghake; J E Gadek; S V Szapiel; O Kawanami; V J Ferrans; R G Crystal
Journal:  Am Rev Respir Dis       Date:  1984-05

7.  Chronic graft-versus-host disease (GVHD) as a model for scleroderma. I. Description of model systems.

Authors:  B D Jaffee; H N Claman
Journal:  Cell Immunol       Date:  1983-04-01       Impact factor: 4.868

8.  Keloid fibroblasts exhibit an altered response to TGF-beta.

Authors:  M Babu; R Diegelmann; N Oliver
Journal:  J Invest Dermatol       Date:  1992-11       Impact factor: 8.551

9.  Phosphatidylinositol 3-kinase is involved in alpha2(I) collagen gene expression in normal and scleroderma fibroblasts.

Authors:  Yoshihide Asano; Hironobu Ihn; Kenichi Yamane; Masatoshi Jinnin; Yoshihiro Mimura; Kunihiko Tamaki
Journal:  J Immunol       Date:  2004-06-01       Impact factor: 5.422

10.  Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells.

Authors:  E Van Obberghen-Schilling; N S Roche; K C Flanders; M B Sporn; A B Roberts
Journal:  J Biol Chem       Date:  1988-06-05       Impact factor: 5.157

View more
  31 in total

1.  Suramin inhibits renal fibrosis in chronic kidney disease.

Authors:  Na Liu; Evelyn Tolbert; Maoyin Pang; Murugavel Ponnusamy; Haidong Yan; Shougang Zhuang
Journal:  J Am Soc Nephrol       Date:  2011-05-26       Impact factor: 10.121

Review 2.  siRNA- and miRNA-based therapeutics for liver fibrosis.

Authors:  Zhen Zhao; Chien-Yu Lin; Kun Cheng
Journal:  Transl Res       Date:  2019-08-13       Impact factor: 7.012

Review 3.  Pharmacotherapy of systemic sclerosis.

Authors:  Arnold E Postlethwaite; L Jeff Harris; Syed H Raza; Swapna Kodura; Titilola Akhigbe
Journal:  Expert Opin Pharmacother       Date:  2010-04       Impact factor: 3.889

4.  SHIP-deficient mice develop spontaneous intestinal inflammation and arginase-dependent fibrosis.

Authors:  Keith W McLarren; Alexandra E Cole; Shelley B Weisser; Nicole S Voglmaier; Victoria S Conlin; Kevan Jacobson; Oana Popescu; Jean-Luc Boucher; Laura M Sly
Journal:  Am J Pathol       Date:  2011-05-07       Impact factor: 4.307

5.  Transforming growth factor-β-induced differentiation of airway smooth muscle cells is inhibited by fibroblast growth factor-2.

Authors:  Michael Schuliga; Aqeel Javeed; Trudi Harris; Yuxiu Xia; Chengxue Qin; Zhexing Wang; Xuehua Zhang; Peter V S Lee; Blanca Camoretti-Mercado; Alastair G Stewart
Journal:  Am J Respir Cell Mol Biol       Date:  2012-12-13       Impact factor: 6.914

6.  Chitosan dressing promotes healing in third degree burns in mice: gene expression analysis shows biphasic effects for rapid tissue regeneration and decreased fibrotic signaling.

Authors:  Ruth M Baxter; Tianhong Dai; Jess Kimball; Eugenia Wang; Michael R Hamblin; William P Wiesmann; Simon J McCarthy; Shenda M Baker
Journal:  J Biomed Mater Res A       Date:  2012-07-30       Impact factor: 4.396

7.  Proteomic analysis of CTGF-activated lung fibroblasts: identification of IQGAP1 as a key player in lung fibroblast migration.

Authors:  Galina S Bogatkevich; Anna Ludwicka-Bradley; C Beth Singleton; Jennifer R Bethard; Richard M Silver
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-08-01       Impact factor: 5.464

8.  Serine-threonine kinase receptor-associated protein (STRAP) regulates translation of type I collagen mRNAs.

Authors:  Milica Vukmirovic; Zarko Manojlovic; Branko Stefanovic
Journal:  Mol Cell Biol       Date:  2013-08-05       Impact factor: 4.272

9.  Suramin inhibits the development and progression of peritoneal fibrosis.

Authors:  Chongxiang Xiong; Na Liu; Lu Fang; Shougang Zhuang; Haidong Yan
Journal:  J Pharmacol Exp Ther       Date:  2014-08-28       Impact factor: 4.030

10.  Inflammation and tissue repair markers distinguish the nodular sclerosis and mixed cellularity subtypes of classical Hodgkin's lymphoma.

Authors:  A Birgersdotter; K R N Baumforth; A Porwit; J Sjöberg; W Wei; M Björkholm; P G Murray; I Ernberg
Journal:  Br J Cancer       Date:  2009-09-22       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.